Skip to main content
Figure 2 | BMC Medical Genomics

Figure 2

From: Transcriptomic signature of Bexarotene (Rexinoid LGD1069) on mammary gland from three transgenic mouse mammary cancer models

Figure 2

Deregulated transcripts in mammary gland by systemic treatment with bexarotene in the three transgenic mice mammary cancer models. A. Scatter-plot representation of differentially expressed genes between bexarotene treated mice and vehicle control SAGE libraries (p < 0.05). B. Gene ontology (GO) classification of bexarotene induced differentially expressed transcripts on mammary gland from the different transgenic models. Relative representation of the deregulated transcripts with specific GO term annotations related to biological processes or molecular function.

Back to article page